Sort by
Refine Your Search
-
cancer progression, immune evasion, and therapeutic resistance. We place a strong emphasis on the use of spatial biological approaches applied to human tumour models including organ/tumour perfusion, slice
-
renewable award. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of approaches including targeted genetic murine models, primary cell
-
interpretation of atmospheric circulation in high-resolution reanalysis data, idealised model simulations and a state-of-the-art weather forecasting system. The post-holder will have the opportunity to teach
-
to the 4th February 2026. You will be investigating the safety and security implications of large language model (LLM) agents, particularly those capable of interacting with operating systems and external APIs
-
work with in vitro and in vivo models of genetic diseases would be advantageous. Please see the below 'Job Description' for further details on the role, responsibilities, and selection criteria, as
-
human tumour models including organ/tumour perfusion, slice culture and organoids to ensure data is clinically relevant and to inspire the next generation of effective treatments. The post would suit
-
structural), ECG, and genetics, to model disease trajectories and improve risk prediction in cardiomyopathies. The successful applicant will work closely with the PI to deliver research projects, supervise
-
/weather observational and modelling products would be of a substantial value. Furthermore, experience with epidemiological modelling and/or attribution of extreme events and their impacts in a changing
-
Haematology Unit. You will use state-of-the-art genetic tools and functional genomics to generate and characterize models of CH and ageing, including the role of the bone marrow microenvironment in
-
an industry partnered project for translational drug discovery. The role will involve analysing large scale omics and spatial datasets from both primary patient samples and advanced in vitro model systems